Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comparative Study
. 1992 Feb;51(2):177-81.
doi: 10.1136/ard.51.2.177.

Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis

Affiliations
Comparative Study

Validity of single variables and composite indices for measuring disease activity in rheumatoid arthritis

D M van der Heijde et al. Ann Rheum Dis. 1992 Feb.

Abstract

There is no agreement as to which variable best mirrors disease activity in rheumatoid arthritis (RA) and no studies have been performed on the validity of disease activity variables. In this study the validity of 10 commonly used single variables and three composite indices was tested. All patients participated in a large follow up study in two clinics. The patients (n = 233) had classical or definite RA and a disease duration of less than one year at entry. The mean follow up time was 30 months; the follow up frequency was once every four weeks; 6011 records were used in the analysis. The validation criteria included correlations with the other variables (correlational validity), with the physical disability (criterion validity I), and with the radiographically determined damage of hands and feet (construct validity). The judgment of a group of rheumatologists in clinical practice was also used as a model of criterion validity (II). In this comparison the disease activity score and Mallya index showed the best validity. The best single variable was the number of swollen joints. The validity of most single variables was poor and these variables were not suitable as single endpoint measures in clinical trials.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Ann Rheum Dis. 1990 Nov;49(11):916-20 - PubMed
    1. Rheumatol Rehabil. 1981 Feb 1;20(1):14-7 - PubMed
    1. Arthritis Rheum. 1989 Feb;32(2):221-9 - PubMed
    1. Lancet. 1986 Aug 16;2(8503):377-80 - PubMed
    1. Scand J Rheumatol. 1987;16(6):407-11 - PubMed

Publication types